Want to join the conversation?
$ALXN said that it has initiated the funding processes with healthcare authorities in major European countries for both Strensiq and Kanuma products. The company expects to start serving patients in initial countries outside of Germany in 2H16, with additional countries to follow in 2017
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.